Increased pulmonary toxicity results from a 1-day versus 2-day schedule of administration of high-dose melphalan.
Lori
L
Williams
Roy A
RA
Beveridge
Robert M
RM
Rifkin
Robert L
RL
Bretzel
Luceli
L
Cuasay
Julie L
JL
Alley
Joseph
J
McGuirk
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000633:toxicity; D004334:Drug Administration Schedule; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced*; D008558:Melphalan / Q000008:administration & dosage / Q000633:toxicity*; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy; D011336:Probability; D014182:Transplantation, Autologous
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan